1. Home
  2. RDY vs CXM Comparison

RDY vs CXM Comparison

Compare RDY & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • CXM
  • Stock Information
  • Founded
  • RDY 1984
  • CXM 2009
  • Country
  • RDY India
  • CXM United States
  • Employees
  • RDY N/A
  • CXM N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • CXM Computer Software: Prepackaged Software
  • Sector
  • RDY Health Care
  • CXM Technology
  • Exchange
  • RDY Nasdaq
  • CXM Nasdaq
  • Market Cap
  • RDY 2.1B
  • CXM 2.1B
  • IPO Year
  • RDY N/A
  • CXM 2021
  • Fundamental
  • Price
  • RDY $14.49
  • CXM $9.01
  • Analyst Decision
  • RDY Strong Buy
  • CXM Hold
  • Analyst Count
  • RDY 2
  • CXM 14
  • Target Price
  • RDY $16.95
  • CXM $10.00
  • AVG Volume (30 Days)
  • RDY 1.4M
  • CXM 3.3M
  • Earning Date
  • RDY 07-28-2025
  • CXM 09-03-2025
  • Dividend Yield
  • RDY 0.56%
  • CXM N/A
  • EPS Growth
  • RDY 1.47
  • CXM 90.78
  • EPS
  • RDY 0.79
  • CXM 0.40
  • Revenue
  • RDY $3,809,801,863.00
  • CXM $805,936,000.00
  • Revenue This Year
  • RDY $10.24
  • CXM $4.75
  • Revenue Next Year
  • RDY N/A
  • CXM $4.87
  • P/E Ratio
  • RDY $18.37
  • CXM $22.54
  • Revenue Growth
  • RDY 16.61
  • CXM 6.75
  • 52 Week Low
  • RDY $12.26
  • CXM $6.75
  • 52 Week High
  • RDY $16.89
  • CXM $9.93
  • Technical
  • Relative Strength Index (RSI)
  • RDY 43.00
  • CXM 58.43
  • Support Level
  • RDY $14.51
  • CXM $8.61
  • Resistance Level
  • RDY $14.70
  • CXM $9.18
  • Average True Range (ATR)
  • RDY 0.16
  • CXM 0.29
  • MACD
  • RDY -0.06
  • CXM 0.02
  • Stochastic Oscillator
  • RDY 23.42
  • CXM 79.81

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

Share on Social Networks: